{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:35:44Z","timestamp":1792074944314,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Falls are the leading cause of injury-related death among older Americans. While some research has found that insomnia heightens falls, health care resource utilization (HCRU) and costs, the impact of insomnia treatments on fall risk, mortality, HCRU and costs in the elderly population, which could be of substantial interest to payers, has not been fully elucidated. This study evaluated the risk of falls and related consequences among adults\u2009\u2265\u200965\u00a0years of age treated with common prescription medications for insomnia compared with non-sleep disordered controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective cohort analysis of deidentified Medicare claims from January 2011 through December 2017. Medicare beneficiaries treated for insomnia receiving zolpidem extended-release, zolpidem immediate-release, trazodone, or benzodiazepines were matched with non-sleep disordered controls. The main outcomes were falls, mortality, healthcare resource utilization (HCRU), and medical costs during the 12\u00a0months following the earliest fill date for the insomnia medication of interest. Generalized linear models controlled for several key covariates, including age, race, sex, geographic region and Charlson Comorbidity Index score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 1,699,913 Medicare beneficiaries (59.9% female, mean age 75\u00a0years). Relative to controls, adjusted analyses showed that beneficiaries receiving insomnia medication experienced over twice as many falls (odds ratio [OR]\u2009=\u20092.34, 95% CI: 2.31\u20132.36). In adjusted analyses, patients receiving benzodiazepines or trazodone had the greatest risk. Crude all-cause mortality rates were 15-times as high for the insomnia-treated as controls. Compared with controls, beneficiaries receiving insomnia treatment demonstrated higher estimated adjusted mean number of inpatient, outpatient, and emergency department visits and longer length of inpatient stay. All-cause total adjusted mean costs were higher among insomnia treated patients ($967 vs $454).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Individuals receiving insomnia treatment had an increased risk of falls and mortality and higher HCRU and costs compared with matched beneficiaries without sleep disorders. Trazodone and benzodiazepines were associated with the greatest risk of falls. This analysis suggests that significant risks are associated with common, older generation insomnia medication treatments in the elderly. Nonetheless, these results should be interpreted with caution as the use of these medications may be indicative of underlying morbidity with potential for residual confounding.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12877-022-03165-6","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T06:07:48Z","timestamp":1654322868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines"],"prefix":"10.1186","volume":"22","author":[{"given":"Diana T.","family":"Amari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Juday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feride H.","family":"Frech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Norman","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson M.","family":"Wickwire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,4]]},"reference":[{"issue":"37","key":"3165_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6537a2","volume":"65","author":"G Bergen","year":"2016","unstructured":"Bergen G, Stevens MR, Burns ER. Falls and fall injuries among adults aged >\/=65 Years - United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(37):993\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"3165_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00198-009-1100-1","volume":"21","author":"S Heinrich","year":"2010","unstructured":"Heinrich S, Rapp K, Rissmann U, Becker C, K\u00f6nig HH. Cost of falls in old age: a systematic review. Osteoporos Int. 2010;21(6):891\u2013902.","journal-title":"Osteoporos Int"},{"issue":"1","key":"3165_CR3","first-page":"56","volume":"101","author":"L Croke","year":"2020","unstructured":"Croke L. Beers criteria for inappropriate medication use in older patients: an update from the AGS. Am Fam Physician. 2020;101(1):56\u20137.","journal-title":"Am Fam Physician"},{"key":"3165_CR4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.","edition":"5th"},{"issue":"5","key":"3165_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.sleep.2009.09.012","volume":"11","author":"AN Roy","year":"2010","unstructured":"Roy AN, Smith M. Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization. Sleep Med. 2010;11(5):462\u20139.","journal-title":"Sleep Med"},{"issue":"2","key":"3165_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5665\/sleep.3410","volume":"37","author":"SM Bertisch","year":"2014","unstructured":"Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999\u20132010. Sleep. 2014;37(2):343\u20139.","journal-title":"Sleep"},{"issue":"2","key":"3165_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1124\/pr.117.014381","volume":"70","author":"T Atkin","year":"2018","unstructured":"Atkin T, Comai S, Gobbi G. Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery. Pharmacol Rev. 2018;70(2):197\u2013245.","journal-title":"Pharmacol Rev"},{"key":"3165_CR8","doi-asserted-by":"publisher","first-page":"e4614","DOI":"10.7717\/peerj.4614","volume":"6","author":"A Mokhar","year":"2018","unstructured":"Mokhar A, Tillenburg N, Dirmaier J, Kuhn S, H\u00e4rter M, Verthein U. Potentially inappropriate use of benzodiazepines and z-drugs in the older population\u2014analysis of associations between long-term use and patient-related factors. PeerJ. 2018;6:e4614.","journal-title":"PeerJ"},{"issue":"4","key":"3165_CR9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"American Geriatrics Society","year":"2019","unstructured":"American Geriatrics Society. American geriatrics society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"3165_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","volume":"13","author":"MJ Sateia","year":"2017","unstructured":"Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of sleep medicine clinical practice guideline. J Clin Sleep Med\u202f: JCSM. 2017;13(2):307\u201349.","journal-title":"J Clin Sleep Med : JCSM"},{"key":"3165_CR11","doi-asserted-by":"publisher","first-page":"89S","DOI":"10.1097\/00004714-198111001-00016","volume":"1","author":"R Newton","year":"1981","unstructured":"Newton R. The side effect profile of trazodone in comparison to an active control and placebo. J Clin Psychopharmacol. 1981;1:89S-93S.","journal-title":"J Clin Psychopharmacol"},{"issue":"7\u20138","key":"3165_CR12","first-page":"24","volume":"14","author":"KY Jaffer","year":"2017","unstructured":"Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017;14(7\u20138):24\u201334.","journal-title":"Innov Clin Neurosci"},{"issue":"21","key":"3165_CR13","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.2020.19224","volume":"324","author":"J Wong","year":"2020","unstructured":"Wong J, Murray Horwitz M, Bertisch SM, Herzig SJ, Buysse DJ, Toh S. Trends in dispensing of zolpidem and low-dose trazodone among commercially insured adults in the United States, 2011\u20132018. JAMA. 2020;324(21):2211.","journal-title":"JAMA"},{"issue":"4","key":"3165_CR14","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.4088\/JCP.16m10713","volume":"78","author":"DT Maust","year":"2017","unstructured":"Maust DT, Blow FC, Wiechers IR, Kales HC, Marcus SC. National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary care. J Clin Psychiatry. 2017;78(4):e363\u201371.","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"3165_CR15","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.5665\/sleep.3914","volume":"37","author":"ES Ford","year":"2014","unstructured":"Ford ES, Wheaton AG, Cunningham TJ, Giles WH, Chapman DP, Croft JB. Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the national ambulatory medical care survey 1999\u20132010. Sleep. 2014;37(8):1283\u201393.","journal-title":"Sleep"},{"issue":"3","key":"3165_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jagp.2018.10.017","volume":"27","author":"JS Albrecht","year":"2019","unstructured":"Albrecht JS, Wickwire EM, Vadlamani A, Scharf SM, Tom SE. Trends in insomnia diagnosis and treatment among Medicare beneficiaries, 2006\u20132013. Am J Geriatr Psychiatry. 2019;27(3):301\u20139.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"3165_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.emc.2006.01.005","volume":"24","author":"MT Aschkenasy","year":"2006","unstructured":"Aschkenasy MT, Rothenhaus TC. Trauma and falls in the elderly. Emerg Med Clin North Am. 2006;24(2):413\u201332, vii.","journal-title":"Emerg Med Clin North Am"},{"issue":"Suppl 4","key":"3165_CR18","doi-asserted-by":"crossref","first-page":"Iv2","DOI":"10.1136\/ip.8.suppl_4.iv2","volume":"8","author":"S Binder","year":"2002","unstructured":"Binder S. Injuries among older adults: the challenge of optimizing safety and minimizing unintended consequences. Inj Prev. 2002;8(Suppl 4):Iv2-4.","journal-title":"Inj Prev"},{"key":"3165_CR19","unstructured":"SGIM. Medicare Claims Data. Available at: https:\/\/www.sgim.org\/communities\/research\/dataset-compendium\/medicare-claims-data."},{"key":"3165_CR20","unstructured":"U.S. Bureau of Labor Statistics. Measuring Price Change in the CPI: Medical care. Available at: https:\/\/www.bls.gov\/cpi\/factsheets\/medical-care.htm. Accessed August 26th."},{"issue":"5","key":"3165_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"11","key":"3165_CR22","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.clinthera.2016.09.010","volume":"38","author":"JL Schroeck","year":"2016","unstructured":"Schroeck JL, Ford J, Conway EL, et al. Review of safety and efficacy of sleep medicines in older adults. Clin Ther. 2016;38(11):2340\u201372.","journal-title":"Clin Ther"},{"issue":"12","key":"3165_CR23","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.jagp.2017.08.014","volume":"25","author":"JC Macri","year":"2017","unstructured":"Macri JC, Iaboni A, Kirkham JG, et al. Association between antidepressants and fall-related injuries among long-term care residents. Am J Geriatr Psychiatry. 2017;25(12):1326\u201336.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10","key":"3165_CR24","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1111\/jgs.15519","volume":"66","author":"SE Bronskill","year":"2018","unstructured":"Bronskill SE, Campitelli MA, Iaboni A, et al. Low-dose trazodone, benzodiazepines, and fall-related injuries in nursing homes: a matched-cohort study. J Am Geriatr Soc. 2018;66(10):1963\u201371.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"3165_CR25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2869.2011.00928.x","volume":"20","author":"AJ Roth","year":"2011","unstructured":"Roth AJ, McCall WV, Liguori A. Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs. J Sleep Res. 2011;20(4):552\u20138.","journal-title":"J Sleep Res"},{"issue":"4","key":"3165_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2125.1983.tb02180.x","volume":"16","author":"AJ Bayer","year":"1983","unstructured":"Bayer AJ, Pathy MS, Ankier SI. Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly. Br J Clin Pharmacol. 1983;16(4):371\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3165_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jbmr.3619","volume":"34","author":"JA Cauley","year":"2019","unstructured":"Cauley JA, Hovey KM, Stone KL, et al. Characteristics of Self-Reported Sleep and the Risk of Falls and Fractures: The Women\u2019s Health Initiative (WHI). J Bone Miner Res. 2019;34(3):464\u201374.","journal-title":"J Bone Miner Res"},{"key":"3165_CR28","doi-asserted-by":"crossref","unstructured":"Chen TY, Lee S, Buxton OM. A Greater Extent of Insomnia Symptoms and Physician-Recommended Sleep Medication Use Predict Fall Risk in Community-Dwelling Older Adults. Sleep. 2017;40(11).","DOI":"10.1093\/sleep\/zsx142"},{"issue":"1","key":"3165_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11136-016-1374-7","volume":"26","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Cifuentes M, Gao X, Amaral G, Tucker KL. Age- and gender-specific associations between insomnia and falls in Boston Puerto Rican adults. Qual Life Res. 2017;26(1):25\u201334.","journal-title":"Qual Life Res"},{"issue":"6","key":"3165_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1532-5415.2005.53304.x","volume":"53","author":"AY Avidan","year":"2005","unstructured":"Avidan AY, Fries BE, James ML, Szafara KL, Wright GT, Chervin RD. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc. 2005;53(6):955\u201362.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"3165_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/jgs.12649","volume":"62","author":"KL Stone","year":"2014","unstructured":"Stone KL, Blackwell TL, Ancoli-Israel S, et al. Sleep disturbances and risk of falls in older community-dwelling men: the outcomes of sleep disorders in older men (MrOS Sleep) study. J Am Geriatr Soc. 2014;62(2):299\u2013305.","journal-title":"J Am Geriatr Soc"},{"key":"3165_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/DHPS.S14955","volume":"2","author":"AY Avidan","year":"2010","unstructured":"Avidan AY, Palmer LA, Doan JF, Baran RW. Insomnia medication use and the probability of an accidental event in an older adult population. Drug Healthc Patient Saf. 2010;2:225\u201332.","journal-title":"Drug Healthc Patient Saf"},{"issue":"7526","key":"3165_CR33","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanct\u00f4t KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ (Clinical research ed). 2005;331(7526):1169.","journal-title":"BMJ (Clinical research ed)"},{"issue":"1","key":"3165_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jhm.1985","volume":"8","author":"BP Kolla","year":"2013","unstructured":"Kolla BP, Lovely JK, Mansukhani MP, Morgenthaler TI. Zolpidem is independently associated with increased risk of inpatient falls. J Hosp Med. 2013;8(1):1\u20136.","journal-title":"J Hosp Med"},{"issue":"4","key":"3165_CR35","doi-asserted-by":"publisher","first-page":"371.e11","DOI":"10.1016\/j.jamda.2017.12.098","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"Seppala LJ, Wermelink A, de Vries M, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11-.e17.","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"3165_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.5665\/sleep.5742","volume":"39","author":"SE Tom","year":"2016","unstructured":"Tom SE, Wickwire EM, Park Y, Albrecht JS. Nonbenzodiazepine sedative hypnotics and risk of fall-related injury. Sleep. 2016;39(5):1009\u201314.","journal-title":"Sleep"},{"key":"3165_CR37","doi-asserted-by":"publisher","first-page":"110962","DOI":"10.1016\/j.exger.2020.110962","volume":"136","author":"FV Machado","year":"2020","unstructured":"Machado FV, Louzada LL, Cross NE, Camargos EF, Dang-Vu TT, N\u00f3brega OT. More than a quarter century of the most prescribed sleeping pill: systematic review of zolpidem use by older adults. Exp Gerontol. 2020;136:110962.","journal-title":"Exp Gerontol"},{"issue":"3","key":"3165_CR38","first-page":"218","volume":"68","author":"H Slaney","year":"2015","unstructured":"Slaney H, MacAulay S, Irvine-Meek J, Murray J. Application of the beers criteria to alternate level of care patients in hospital inpatient units. Can J Hosp Pharm. 2015;68(3):218\u201325.","journal-title":"Can J Hosp Pharm"},{"issue":"47","key":"3165_CR39","doi-asserted-by":"publisher","first-page":"E1376","DOI":"10.1503\/cmaj.180551","volume":"190","author":"JA Watt","year":"2018","unstructured":"Watt JA, Gomes T, Bronskill SE, et al. Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study. CMAJ. 2018;190(47):E1376\u201383.","journal-title":"CMAJ"},{"issue":"2","key":"3165_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bcp.12617","volume":"80","author":"K Ruxton","year":"2015","unstructured":"Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(2):209\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"3165_CR41","doi-asserted-by":"publisher","first-page":"e0137117","DOI":"10.1371\/journal.pone.0137117","volume":"10","author":"M DiBonaventura","year":"2015","unstructured":"DiBonaventura M, Richard L, Kumar M, Forsythe A, Flores NM, Moline M. The association between insomnia and insomnia treatment side effects on health status, work productivity, and healthcare resource use. PLoS One. 2015;10(10):e0137117.","journal-title":"PLoS One"},{"issue":"1","key":"3165_CR42","doi-asserted-by":"publisher","first-page":"zsz192","DOI":"10.1093\/sleep\/zsz192","volume":"43","author":"EM Wickwire","year":"2020","unstructured":"Wickwire EM, Vadlamani A, Tom SE, Johnson AM, Scharf SM, Albrecht JS. Economic aspects of insomnia medication treatment among Medicare beneficiaries. Sleep. 2020;43(1):zsz192.","journal-title":"Sleep"},{"issue":"4","key":"3165_CR43","doi-asserted-by":"publisher","first-page":"zsz007","DOI":"10.1093\/sleep\/zsz007","volume":"42","author":"EM Wickwire","year":"2019","unstructured":"Wickwire EM, Tom SE, Scharf SM, Vadlamani A, Bulatao IG, Albrecht JS. Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries. Sleep. 2019;42(4):zsz007.","journal-title":"Sleep"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-03165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-022-03165-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-03165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T12:41:17Z","timestamp":1727354477000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-022-03165-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,4]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3165"],"URL":"https:\/\/doi.org\/10.1186\/s12877-022-03165-6","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,4]]},"assertion":[{"value":"10 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was determined by Advarra to be exempt from institutional review board review under the U.S. Department of Health and Human Services regulations (IRB # 2018\u20130054-GR-NJ). This study was conducted using an anonymous, publicly available secondary dataset that meets the US HIPPA requirement. Ethics approval and consent to participate are not applicable for the current study per US 45 Code of Federal Regulations Part 46, human participant protection regulations, and Protections of Human Subjects. This study was conducted in accordance with the principles of the Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EMW received compensation for consulting on this study. EMW's institution has received research funding from the AASM Foundation, US DoD, Merck, ResMed\u00a0and ResMed Foundation. EMW has served as a scientific consultant to DayZz, Eisai, Merck, and Purdue, and is an equity shareholder in WellTap. TJ, FF and NA are employees of Eisai, Inc. DTA, WW and ZW are employees of Genesis Research, which received compensation for conducting this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"484"}}